comparemela.com

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada ,United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Israel ,United States ,London ,City Of ,Japan ,Australia ,America ,Australian ,Dutch ,Canadian ,Japanese ,Israeli ,Paul Sekhri ,Barbara Yanni ,Deborah Jorn ,Michael Levitan ,Leonard Kruimer ,Foster Mitchell Alex Shaw ,Steven Baert ,Alexander Breidenbach ,Heather Robertson ,Richard Peters ,Mark Pykett ,Drug Administration ,Exchange Commission ,Prnewswire Pharming Groupnv ,International Accounting Standard ,Regulatory Agency ,Pharming Group ,Israeli Ministry Of Health ,Novartis ,Committee For Human Medicinal Products ,Company Euronext Amsterdam ,Therapeutic Goods Administration ,Vp Investor Relations Corporate Communications ,International Accounting Standards Board ,Linkedin ,Access Program ,Expert Group ,Drug Submission To Health Canada ,European Medicines Agency ,Patient Program ,Devices Agency ,Lifespring Life Sciences Communication ,International Financial Reporting Standards ,European Commission Decision Reliance Procedure ,Nasdaq ,Japan Pharmaceuticals ,Ministry Of Health ,Investor Relations Corporate Communications ,Euronext Amsterdam ,Executive Officer ,Sijmen De Vries ,Expanded Access Program ,Open Label Extension ,Priority Review ,Rare Pediatric Disease Priority Review Voucher ,Annual Report ,Human Medicinal Products ,Marketing Authorisation Application ,Ad Hoc Expert Group ,Scientific Advisory Groups ,Orphan Drug Designation ,Medical Devices Agency ,New Drug Submission ,Health Canada ,Product Registration Application ,Israeli Ministry ,Pediatric Investigational Plan ,Investigational New Drug ,Chief Business ,Non Executive Director ,Extraordinary General Meeting ,Chief Business Officer ,Chief Development Officer ,Marketing Authorisation ,Conference Call Dial In Details ,Investor Relations ,Corporate Communications ,Spring Life Sciences Communication ,North America ,Middle East ,Dutch Financial Supervision Act ,Executive Director ,Chief Executive ,Consolidated Interim Financial Statements ,Dutch Civil Code ,Pivot Park ,Orchard Therapeutics ,Executive Committee ,Aktien Sie ,

comparemela.com © 2020. All Rights Reserved.